News
Check this post often as we update it from the dozens of photos conference attendees are sharing from the show.
As part of its ongoing efforts to help healthcare provider organizations enhance their IT strategies and better realize value from their IT investments, HIMSS Analytics is unveiling at HIMSS16 the Next EMRAM Criteria and Value Score.
EMRAM is HIMSS Analytics’ Electronic Medical Record Adoption Model. And Value Score is described by HIMSS Analytics as healthcare’s first international quality measurement for the value of health IT – building on the EMRAM and HIMSS’ Value Suite – to help providers optimize and use IT to improve clinical and financial outcomes and drive efficiencies in care.
The Next EMRAM Criteria is a major update to EMRAM. HIMSS Analytics is shifting some existing technologies and practices down its seven-stage ladder, moving new ones in, better accounting for differences in the delivery of healthcare around the world, and adding significant new material centered on security. HIMSS Analytics is launching the Next EMRAM Criteria at HIMSS16, but added that it still is working through details on some of the revised criteria.
“It’s been an exhaustive process: gathering feedback from the provider, administrative health and vendor communities around the world, but by and large the criteria is fundamentally inked. The intent is to create a true global comparison,” said Blain Newton, executive vice president at HIMSS Analytics. “The previous EMRAM was built 10 years ago, and while it became an effective tool and an industry standard – to the point where bond rating agencies ask for proof of Stage 7 – medicine is practiced differently in different parts of the world, and EMRAM initially was pretty specific to North America.”
Newton said the Next EMRAM Criteria reflects the current state of the market, so things that were cutting edge 10 years ago now are moved down the scale and emerging practices and technologies have been moved in at different stages. For example, picture archiving and communication systems, which were not as commonplace 10 years ago as they are today, have been moved down to an earlier stage, while such things as clinician documentation and business continuity services have been given new emphasis.
“And we’ve added a significant amount of material around privacy and security, which was a missing piece for us,” Newton said. “It’s a big update to the original criteria. But health systems performing well now will still be performing well with the rollout of the Next EMRAM Criteria.”
Also at HIMSS16, HIMSS Analytics is officially launching Value Score, the next generation of several HIMSS-developed standards and resources that have served as health IT adoption models for providers over the last decade. EMRAM, for instance, has helped hospitals and clinical practices track and benchmark EHR adoption and utilization goals, and the HIMSS Health IT Value Suite and Value STEPS have provided a framework and vocabulary for providers to articulate strategies.
As the market continues to evolve, Value Score will give providers a way to look at their entire organization and capture a comprehensive view of how they achieve value beyond the electronic health record, HIMSS Analytics said.
“Value Score is the capstone to all of the offerings,” Newton said. “The other models focus on the adoption and implementation of technology. Value Score is focused on the optimization of that technology to achieve and realize value. It is an objective measure of discrete examples of realizing clinical, financial and patient engagement satisfaction, and realizing value by leveraging IT. We’re not only looking to get to Stage 7, but also to optimize and use IT to truly improve care, reduce costs and increase satisfaction. Value Score is a way to capture and normalize that concept.”
While Value Score measures what is happening today, room has been made for innovation, Newton added, including a score specific to that topic.
“We looked to the folks in the vanguard doing things we haven’t seen before,” he said. “The purpose of Value Score’s innovation score is to push the market forward, so eventually innovation filters down into the core model, which then can evolve and help those not in the vanguard to achieve more and raise the bar for everybody."
HIMSS Analytics is in booth 1054 on the Exhibit Hall floor.
Twitter: @SiwickiHealthIT
This story is part of our ongoing coverage of the HIMSS16 conference. Follow our live blog for real-time updates, and visit Destination HIMSS16 for a full rundown of our reporting from the show. For a selection of some of the best social media posts of the show, visit our Trending at #HIMSS16 hub.
New tool analyzes data to pinpoint care gaps and identify service lines where patients are seeking care elsewhere.
The Patient-Centered Outcomes Research Institute announced a plan to make it easy for individuals to access data in their electronic health records and share it for research that could improve care for their conditions.
A new agreement with FHA will allow DirectTrust's federal partners to operate their Direct implementations within its Security and Trust Framework.
The industry veteran also said that visionary CIOs will start to think about limiting EHR exposure to other tasks.
The new tool builds on the SAP Foundation for Health platform by enabling third-parties to build apps for very specific use cases, like diabetes management, prescription fulfillment or non-adherence issues.
Cybersecurity concerns have become much more than a hypothetical for vulnerable hospitals, most of whom are finally realizing just how vulnerable they are. So it’s no surprise that IT security vendors will surely be among the most visited booths on the HIMSS16 exhibit floor.
Among those: Imprivata will be showcasing the expanded capabilities of its Confirm ID technology, touting new remote access features and two-factor authentication for medical devices.
Initially launched in early 2015 as a comprehensive security tool for e-prescribing of controlled substances, Confirm ID helps providers meet DEA requirements for EPCS while also simplifying eRx workflows in general.
The new platform aims to address, on an enterprise level, other cybersecurity imperatives such as remote employee access, medical device security and in-process authentication for clinical transactions, officials said.
[HIMSS16 survival guide: what you need to know now]
"As healthcare goes digital, critical clinical workflows are using simple usernames and passwords to provide access, making patient information easily vulnerable to hacking," Imprivata CEO Omar Hussain said in a prepared statement.
Imprivata officials said Confirm ID enables fast and secure authentication, protecting workflows against hacking and leaving an auditable "chain of trust" wherever users interact with patient records, financial information or other sensitive data.
"A single, centralized authentication management platform improves security and compliance auditing across the enterprise by enabling better control over how, when, and where users interact with patient records and other sensitive information," added Aaron Miri, chief information officer of Dallas-based Walnut Hill Medical Center.
Miri will discuss Walnut Hill’s use of Imprivata’s identity management and security tools at HIMSS16. Others include Martin Littmann, CTO and CISO at Kelsey-Seybold Clinic, who will present on sstrategies and best practices for achieving EPCS Success, and Rebecca Carter, director of informatics at Bon Secours St. Francis Health System, who will talk about improving patient safety and reducing duplicate records with biometric patient ID.
Plenty of industry partners will also be touting their Imprivata collaborations, with vendors including Allscripts (booth #2612), Cerner (#2032), Citrix (#3412), First Databank (FDB) (#1143), HP (#1332), MEDHOST (#3821), Nuance Communications (#2612), Samsung (#724) and VMware (#2221) displaying the company's tools in their in booths.
Imprivata, meanwhile, can be found at booth #3403.
Twitter: @MikeMiliardHITN
This story is part of our ongoing coverage of the HIMSS16 conference. Follow our live blog for real-time updates, and visit Destination HIMSS16 for a full rundown of our reporting from the show. For a selection of some of the best social media posts of the show, visit our Trending at #HIMSS16 hub.
McKesson is expanding its footprint in the oncology field with a combined $1.2 billion acquisition of two companies – Vantage Oncology and Biologics.
The same week the Hollywood Presbyterian attack was making headlines around the world, another species of ransomware – aptly named "Locky" – was first observed in the wild.